Skip to content

Cardiovascular Risk Factors in an Ambulatory Urban Patient Population

Estimation of Prevalence and Assessment of the Effects of Modification of Cardiovascular Risk Factors in an Ambulatory Urban Patient Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00486993
Acronym
AsuRiesgo
Enrollment
18287
Registered
2007-06-15
Start date
2006-05-31
Completion date
2014-07-31
Last updated
2016-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk Factors, Coronary Artery Disease, Lifestyle Modification, Metabolic Syndrome, Stroke

Keywords

Diet, Exercise, Smoking, Stress, Polyphenols

Brief summary

According to WHO estimations, cardiovascular diseases (CVDs) are the number one cause of death globally. More people die annually from CVDs than from any other cause. An estimated 17.5 million people died from CVDs in 2005, representing 30% of all global deaths. Of these deaths, an estimated 7.6 million were due to coronary heart disease and 5.7 million were due to stroke. Over 80% of CVD deaths take place in low- and middle-income countries and occur almost equally in men and women. In Paraguay, prevalence of classic risk factors, as well as new ones, like the metabolic syndrome are not completely known. Government health policies in industrialized countries are focusing on programs to modify cardiovascular risk factors. In developing countries, prevention of coronary heart disease and stroke through modification of cardiovascular risk factors are not playing a large role at the moment. The aim of this study is to define the effects of changes in lifestyle on cardiovascular risk factors, when added to optimized standard pharmacological therapy for arterial hypertension, diabetes mellitus and hyperlipidemia, in an ambulatory urban patient population.

Interventions

BEHAVIORALDietary and nutritional modification
BEHAVIORALStop smoking
BEHAVIORALRegular physical activities
BEHAVIORALWeight reduction to normal ranges
BEHAVIORALRegular intake of polyphenols, esp. from Ilex paraguayensis

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all ambulatory patients, with age 18 years or older

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frame
cardiovascular mortalityone year

Secondary

MeasureTime frame
mortality, other causesone year
acute myocardial infarctionone year
strokeone year
acute coronary syndromeone year

Countries

Paraguay

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026